Author

L. Le Cam

Observed name: Liz Cam

Institution: Intellia Therapeutics (United States)

Observed institution: Intellia Therapeutics (United States)

OpenAlex ID: A5083169377

388 Engineering co-stimulation into TCR-T cells via a CD8–41BB fusion receptor enhances efficacy and durability in preclinical models of heme and solid tumor malignancies

2024 · Aaron Prodeus, Ivy Dutta, et al. · Journal for ImmunoTherapy of Cancer

Works count: 1

Citation count:

H-index:

I10-index: